SLC5A1 and Hyperglycemia: Preclinical studies in the 1980s showed that phlorizin treatment could control hyperglycaemia in partially pancreatectomised rats, but clinical application awaited synthetic analogues that evaded intestinal glucosidase degradation and offered improved potency and selectivity to inhibit SGLT2 rather than SGLT1 [5, 6].